Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer’s disease

Neuroscience

Volumn 112, Issue 1, 2002, Pages 75-91

  Bussiere T ^a,c   Friend, P D ^a   Sadeghi, N ^a   Wicinski, B ^a   Lin, G I ^a   Bouras, C ^a,b   Giannakopoulos, P ^b   Robakis, N K ^a   Morrison, J H ^a   Perl, D P ^a   Hof, P R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c ELAN PHARMACEUTICALS   (United States)

Author keywords

Amyloid load; Cavalieri principle; Hippocampus; Immunohistochemistry; Neocortex; Quantitative neuropathology

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; PREDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEROLOGY; SUBICULUM;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID; BIOCHEMISTRY; CEREBRAL CORTEX; COGNITION; DENSITOMETRY; HIPPOCAMPUS; HUMANS; MIDDLE AGED; PREFRONTAL CORTEX;

EID: 0037067074     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00056-8     Document Type: Article

References (43)

1. Microglia, amyloid and dementia in Alzheimer disease. A correlative study
2. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
3. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease
4. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older
5. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype
6. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease
7. Neuronal vulnerability and informatics in human disease
8. Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes
9. Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy
10. Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of tau-positive neurofibrillary tangles
11. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease
12. Subtypes and differential laminar distributions of beta A4 deposits in Alzheimer's disease: Relationship with the intellectual status of 26 cases
13. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease
14. Modeling the relation between neurofibrillary tangles and intellectual status
15. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician
16. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
17. Amyloid beta protein (Aβ) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ 40 or Aβ 42
18. The efficiency of systematic sampling in stereology and its prediction
19. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques
20. Age- and Alzheimer's disease-related changes in neocortical pyramidal neurons: A stereologic triple labeling analysis
21. A new clinical scale for the staging of dementia
22. Visualization of Aβ42 and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42
23. Full-length amyloid-β 1-42 and amino-terminally modified and truncated amyloid-Aβ 42 deposit in diffuse plaques
24. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
25. Soluble pool of Aβ-amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
26. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment
27. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
28. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice
29. Practical approaches to stereology in the setting of aging- and disease-related brain banks
30. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
31. Advanced use of 3-D methods for counting neurons
32. Translating cell biology into therapeutic advances in Alzheimer's disease
33. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
34. Sequence of Aβ-protein deposition in the human medial temporal lobe
35. Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Aβ
36. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease, Neurobiol
37. Aβ-generating enzymes: Recent advances in beta- and gamma-secretase research
38. The rotator
39. The levels of soluble versus insoluble brain Aβ distinguish Alzheimer's disease from normal and pathologic aging
40. Comparison of four staining methods on the detection of neuritic plaques
41. Diffuse type of senile plaques in the brains of Alzheimer-type dementia
42. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining